Ask who answers after the visit ends

Know who owns the next reply

• A named route for questions

  “Who reviews a message about a new symptom, and how do I reach them?”

• The next review

  “Which checks come next, and which findings could call for a different plan?”

• An interruption

  “What happens if I cannot get the product or cannot afford the next bill?”

• A change or a stop

  “How would we discuss stopping or changing treatment?”

Ask about the time beyond the opening offer

In the STEP 1 follow-up, the weight regained during a year off semaglutide equalled about two-thirds of what the group had lost.

That finding describes the study group. It does not decide how long an individual’s treatment lasts.

Ask how continuing care, a change in medicine or stopping would be reviewed with the prescriber.

Keep a record that helps the conversation

Write down what was agreed, who to contact and which questions remain open. Ask for a written reply if an answer is hard to follow.

The FDA’s MedWatch service accepts reports of medicine problems from patients as well as professionals.